• Home
  • Mutual Funds
  • Mirae Asset Healthcare Fund Growth

Return

  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
This Fund:
Sensex:
BankFD:

Showing Funds Performance since Sep 07, 2020

Fund Overview

Min. investment

SIP ₹99 & Lump. ₹5000

AUM (Fund size)

₹2,754 Cr

Lock In Period

N/A

Expense Ratio

1.94

Benchmark

BSE Healthcare Total Return

Exit Load

15% of the units allotted (including Switch-in/STP - in) on or before completion of 365 days from the date of allotment of units: Nil.Any redemption in excess of such limits in the first 365 days from the date of allotment shall be subject to the following exit load: If redeemed within 1 year (365 days) from the date of allotment: 1%If redeemed after 1 year (365 days) from the date of allotment: NIL.

Summary

Latest details for Mirae Asset Healthcare Fund Growth include a ₹40.276 NAV as of Apr 27,2026 and returns since inception of 89.54%. Minimum investments start at SIP ₹99. The Mirae Asset Healthcare Fund Growth AUM is ₹2,754 Cr, with a lock-in of N/A years, expense ratio of 1.94%, and benchmark BSE Healthcare Total Return. Exit load is - 15% of the units allotted (including Switch-in/STP - in) on or before completion of 365 days from the date of allotment of units: Nil.Any redemption in excess of such limits in the first 365 days from the date of allotment shall be subject to the following exit load: If redeemed within 1 year (365 days) from the date of allotment: 1%If redeemed after 1 year (365 days) from the date of allotment: NIL.. In the growth review for 1M Month/Year, the fund recorded 4.75% returns, against a category average of 1.92% and a category best of 5.25%.

Calculate Returns

You would have got

close_grey_icon
No Data Found
Your Investment Amount
  • 1
  • 2
  • 3
  • 4
  • 5

Growth Review

DurationFund Return(%)Category Average(%)Category Best(%)
1M4.751.925.25
6M1.321.508.52
1Y5.725.397.26
3Y23.7617.36104.85

Portfolio Analysis

  • Equity: 99.89%
  • Debt: 0.07%
  • Others
As on: 2026-03-31
View allocation % by

1. Sun Pharmaceutical Industries Ltd.12.20%
2. Divi's Laboratories Ltd.7.93%
3. Glenmark Pharmaceuticals Ltd.6.94%
4. JB Chemicals & Pharmaceuticals Ltd.6.88%
5. Lupin Ltd.5.06%
6. Aurobindo Pharma Ltd.4.32%
7. Dr. Reddy's Laboratories Ltd.4.31%
8. Laurus Labs Ltd.3.56%
9. Cipla Ltd.3.37%
10. IPCA Laboratories Ltd.3.32%
11. Alkem Laboratories Ltd.3.25%
12. Sai Life Sciences Ltd.3.03%
13. Onesource Specialty Pharma Ltd.2.91%
14. Eris Lifesciences Ltd.2.67%
15. Gland Pharma Ltd.1.88%
16. Mankind Pharma Ltd.1.67%
17. Biocon Ltd.1.27%
18. Anthem Biosciences Ltd.1.25%
19. Rubicon Research Ltd.0.85%
20. Torrent Pharmaceuticals Ltd.0.49%
21. Sudeep Pharma Ltd.0.44%
22. Wockhardt Ltd.0.09%
23. Syngene International Ltd.0.00%

1. Apollo Hospitals Enterprise Ltd.6.15%
2. Fortis Healthcare Ltd.3.73%
3. Aster DM Healthcare Ltd.3.44%
4. Krishna Institute of Medical Sciences Ltd.3.26%
5. Dr. Lal Path labs Ltd.1.95%
6. Narayana Hrudayalaya Ltd.1.17%
7. Max Healthcare Institute Ltd.1.11%

About Fund

Mirae Asset Healthcare Fund Growth managed by Mirae Asset Mutual Fund,is a Healthcare & Pharmascheme with Assets Under Management of ₹2,754 Crore. The fund benchmarks its performance against the BSE Healthcare Total Return while maintaining an expense ratio of 1.94. Under the expert guidance of Vrijesh Kasera ,the fund implements a disciplined investment approach aligned with its mandate. The scheme requires a minimum investment of ₹500 for SIP and ₹1,000 for lump sum investments, making it accessible to diverse investor profiles.

Fund Managers

Vrijesh Kasera

Mr. Kasera has professional experience of more than 10 years. He has joined Mirae Asset in Nov’2016 and his primary responsibility includes Investment Analysis & Research. Prior to this assignment, he was associated with Axis Capital Ltd. as an Equity Research Analyst. He has also been associated with Edelweiss Broking Ltd. Mr. Kasera has completed his Post Graduation Diploma in Business Management from IILM and also he has done his Chartered Financial Analyst & Master of Science in Finance from ICFAI University.

Peer Comparison

Fund NameRatingsAUMExpense Ratio
This FundNippon India Pharma Fund Growth47898.24 CR1.82
This FundAditya Birla Sun Life Pharma & Healthcare Fund Growth2858.87 CR2.3
This FundMirae Asset Healthcare Fund Growth42753.72 CR1.94
This FundUTI Healthcare Fund Growth31055.53 CR2.28
This FundICICI Prudential Pharma Healthcare & Diagnostics (P.H.D) Fund Growth56293.14 CR1.87
Fund Name1Y3Y
This FundNippon India Pharma Fund Growth0.75680.8448
This FundAditya Birla Sun Life Pharma & Healthcare Fund Growth2.275784.0356
This FundMirae Asset Healthcare Fund Growth5.720889.5417
This FundUTI Healthcare Fund Growth3.599791.5861
This FundICICI Prudential Pharma Healthcare & Diagnostics (P.H.D) Fund Growth1.955699.6894

FAQs

Mirae Asset Healthcare Fund Growth's fund is managed by experienced SEBI-registered investment fund manager , who implements the fund's strategy through research-backed decisions while adhering to its stated objectives.

The expense ratio of Mirae Asset Healthcare Fund Growth is 1.94. This expense ratio is calculated by dividing the fund's operating expenses by its net assets.

Mirae Asset Healthcare Fund Growth’s fund performance is as follows:
  • 1 Month : 4.75%
  • 6 Months : 1.32%
  • 1 Year : 5.72%
  • 3 Years : 23.76%
Returns of Mirae Asset Healthcare Fund Growth are updated daily based on NAV of ₹ 40.276 as on Apr 27,2026. Since inception, the return has been 89.54%.

You can invest in Mirae Asset Healthcare Fund Growth through SIP with a minimum of ₹500 monthly or make a lump sum investment of a minimum ₹1,000. Additional purchase minimums vary by scheme.

The fund size (AUM) of Mirae Asset Healthcare Fund Growth is ₹2,754 crore. It changes based on market performance, inflows, and outflows.

You can track your investment in Mirae Asset Healthcare Fund Growth through our website, our Choice FinX mobile app, regular statements, and email updates. Our customer support team is available for queries.
Min Inv Amount: ₹500